User: TahirAmin Topic: IP
Category: drugs :: everywhere
Last updated: Apr 01 2019 02:22 IST RSS 2.0
 
1 to 20 of 10,063    
The arrogance of the ignorant 31.3.2019 Hindu: Op-Ed
It is tragic that ‘New India’ chooses to attack Adivasis and forest-dwellers instead of those destroying its ecology
Also found in: [+]
Can Biotechnology be Indian economy's next success story? 16.3.2019 Sify Finance
The information technology industry has provided stellar growth for Indian economy, but as dividends reach an inflection point, here's what biotechnology sector could offer.
Also found in: [+]
Dr Reddy's re-launch generic version of Suboxone in US 21.2.2019 Sify Finance
With US Supreme Court ruling in its favour, Indian pharma major Dr. Reddy's Laboratories on Wednesday announced re-launch of generic version of Suboxone, a sublingual film for opioid addition treatment, in the US market.
Also found in: [+]
Make India the international capital for Generic Medicines: Vice President 21.12.2018 Govt of india: PIB
The Vice President of India, Shri M. Venkaiah Naidu has called up on the pharmaceutical industry to work towards making India an International Capital of Generic Medicines.  Addressing the 70th Indian Pharmaceutical Congress at Amity University, Noida today, Shri Naidu said that India becoming the largest provider of generic drugs globally with the Indian generics accounting for 20 % of global exports in terms of volume was an eloquent testimony to the competence of the Indian pharma sector in terms of quality and pricing.
Also found in: [+]
Innovation is for the betterment of mankind: Vice President 18.11.2018 Govt of india: PIB
The Vice President of India, Shri M. Venkaiah Naidu has said that Innovation is for the betterment of mankind and India is encouraging the spirit of innovation among the educated enterprising youth. He was addressing the gathering after inaugurating the International Conference ‘Asian Patent Attorneys Association’, here today.
Also found in: [+]
J & J's loss may be good news for Indian pharmas 1.11.2018 Rediff: Business
Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga
Also found in: [+]
Big pharma firms set to return to double-digit growth 29.10.2018 Financial Chronicle
New Delhi After two consecutive years of single-digit expansion, big drug firms are expected to return to double-digit growth in the current fiscal aided by recovery in US sales, weakening of the rupee and revival of domestic demand, ratings agency Crisil said. Meanwhile, another report suggests that the recent guidance from the USFDA will help domestic drug manufacturers to understand new drug applications process, so that they would be able to get pending applications approved. As per Crisil, the return to double-digit growth would help the homegrown pharma companies, with turnover of Rs 1,000 crore or more, to weather a sharp rise in input costs. The agency in its report said, green shoots are already visible in the first quarter for 20 of these listed drug-makers, which account for three-fourths of the pharma industry revenue. The US and the domestic markets contribute on average 30 per cent and 35 per cent of their revenues, respectively. “The US market is witnessing an upturn after de-growth in ...
Also found in: [+]
IIT Delhi students develop cheaper drug for curing snake bites 11.9.2018 Zee News : India National
The product has shown efficacy against rattlesnake and viper venoms and is undergoing further testing.
Also found in: [+]
'This movie has made China introspect and learn from India' 21.7.2018 Rediff: Columns
Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to change its policy towards Indian pharmaceutical companies, says Tarun Vijay.
Also found in: [+]
Will this movie change China's drug policy towards India? 14.7.2018 Rediff: News
Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to change its policy towards Indian pharmaceutical companies, says Tarun Vijay.
Also found in: [+]
Dr. Reddy’s new drug hits legal hurdle 16.6.2018 Hindu: Policy & Issues
U.S. court issues restraint order following patent litigation over Suboxone
Also found in: [+]
Apple patents BP monitoring 'cuff' 8.6.2018 Sify Finance
Apple has patented a design for a wearable blood pressure monitor -- a cuff, equipped with a sensor that is expected to be Bluetooth compatible and sport a touchscreen.
Also found in: [+]
Gap in regulating biotech drug copies prompts WHO to step in 30.5.2018 General News
LONDON (Reuters) - Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and poor countries alike - but uneven regulation has created a lopsided market.
Also found in: [+]
AstraZeneca opens another medicines development centre 30.5.2018 General News
Bio-pharmaceutical company AstraZeneca officially opened its new Global Medicines Development (GMD) centre here today. The unit is one of AstraZeneca's nine GMD centres that the company has around the world that transforms breakthrough molecules into medicines and monitors their use and safety, the company said in a press release. With this opening, India would now play an even bigger role in AstraZeneca's global operations, the release said. The GMD Bengaluru team would focus on supporting AstraZeneca's medicines which covers treatments across a range of therapies, including oncological, respiratory and cardiovascular and metabolic diseases, it said. GMD Bengaluru plays a key role supporting 51 of AstraZenecas mature brands which are used by patients around the world. Last year, the team recruited scientific experts in the fields of regulatory science, clinical, and patient safety, and has grown from 30 to 70 people. The expansion would see a further increase to more ...
Also found in: [+]
Roche, chasing Merck, notches another lung cancer win 29.5.2018 General News
ZURICH (Reuters) - Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker said its immunotherapy Tecentriq mixed with chemotherapy boosted lung cancer patients' survival.
Also found in: [+]
EU makes it easier for companies to produce generic medicines for export 28.5.2018 General News
BRUSSELS (Reuters) - The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic drugs for export to countries and regions where they are not under extended patent protection.
Also found in: [+]
Dr. Reddy’s arm files patent infringement lawsuit 26.5.2018 Hindu: Hyderabad
Promius Pharma LLC, a wholly owned subsidiary of Dr. Reddy’s Laboratories, has filed a lawsuit for patent infringement in a US court against Perrigo U
Also found in: [+]
Sun Pharma warns U.S. pricing pressure to hit 2019 profit 25.5.2018 General News
(Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Friday it expects its 2019 revenue to come in short of analysts' expectations due to pricing pressure in its main market, the United States.
Also found in: [+]
Dr Reddy'sfiles patent infringement case againstPerrigo UK & 25.5.2018 General News
Dr Reddy's Laboratories Limited today said subsidiary Promius Pharma LLC, has filed a patent infringement lawsuit in a US court against Perrigo UK Finco Limited Partnership, Perrigo Israel Pharmaceuticals Ltd. and Taro Pharmaceuticals, Inc over its topical spray Sernivo. In a filing with the bourses,it said the case was filed in the United States District Court for Eastern District of Texas against the three companies "in response to two paragraph-IV notice letters received for its twice daily topical spray Sernivo (betamethasone dipropionate, 0.05%) product." A notice under Paragrap IV will be issued to a patent holder when a generic company wants to make a similar drug. Promius said it anticipates this lawsuit will trigger a 30 month stay of Food and Drug Administration approval of Perrigo's and Taro's Abbreviated New Drug Application (ANDA). Sernivo spray is protected by six Orange Book patents that expire in 2030. The publication Approved Drug Products with Therapeutic
Also found in: [+]
Dr Reddys Laboratories' subsidiary files lawsuit for patent infringement in US 25.5.2018 General News
SERNIVO spray, 0.05% is protected by six Orange Book patents that expire in 2030. Promius will continue to vigorously defend its SERNIVO intellectual property rights against infringement wherever they are challenged
Also found in: [+]
1 to 20 of 10,063